NAAA-IN-3
Product Specifications
UNSPSC Description
NAAA-IN-3 (Compound 17a) is a potent and selective inhibitor of NAAA with an IC50 of 50 nM. NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanolamide (OEA). NAAA-IN-3 has the potential for the research of inflammation and pain[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/naaa-in-3.html
Solubility
10 mM in DMSO
Smiles
N#CN1CC(C1)OCC2=CC=C(C=C2)C3=CC=CC=C3
Molecular Weight
264.32
References & Citations
[1]Malamas MS, et al. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. Bioorg Med Chem. 2020 Jan 1;28(1):115195.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147775/NAAA-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147775/
Clinical Information
No Development Reported
CAS Number
1831115-59-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
